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Table 1
Phenotypes of Affected Sib Pairs with AITD
NO. WITH PHENOTYPE
SIB-PAIR TYPE GD-GDa GD-AHb All AITD
Full 66 6 72
Half 5 0 5
Total 71 6 77
a Sib pairs with GD only.
b Sib pairs with mixed GD and autoimmune hypothyroid. Families
were selected on the basis of two affected sibs with GD. GD-AH sib
pairs make up additional members of the same families.
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Further Evidence for a Susceptibility Locus
on Chromosome 20q13.11 in Families
with Dominant Transmission of Graves Disease
To the Editor:
The susceptibility loci for Graves disease (GD [MIM
275000]), which is a common complex trait (Brix et al.
1998), have been difficult to define (Roman et al. 1992;
McLachlan 1993; Davies 1998; Farid 1998; Vaidya et
al. 1999). Tomer et al. (1998) recently found evidence
for linkage of GD to markers on the long arm of chro-
mosome 20 (MIM 603388), with a peak multipoint
LOD score of 3.5 at the marker D20S195. Their linkage
analysis was performed by both parametric and non-
parametric methods, and their cohort of 53 families with
at least two first-degree relatives affected with autoim-
mune thyroid disease (AITD) was derived from the
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Figure 1 Linkage analysis in all 64 affected GD kindreds. A,
Percentage information content shown at each of the map positions.
B, Multipoint nonparametric linkage analysis of kindreds with GD for
chromosome 20q13.11 markers. Genotyping was performed by PCR
with fluorescently labeled Ge´ne´thon markers (Dib et al. 1996) and
was resolved by use of a laser detection system (ABI). Linkage analysis
was performed by the “score all” function of GENEHUNTER (Krug-
lyak et al. 1996), with either GD or AITD as the affected phenotype.
The marker order and genetic distances shown are derived from our
own data and correspond closely to the sex-averaged Ge´ne´thon and
Marshfield Medical Research Foundation Center for Medical Genetics
maps (Dib et al. 1996; Broman et al. 1998). There is no evidence for
linkage of GD or AITD to any of the five markers studied.C, Exclusion
mapping of chromosome 20q13.11 as a GD-susceptibility region. The
“exclude” function of GENEHUNTER was used to plot the proba-
bility (LOD score) that 20q13.11 contained a hypothetical GD locus
with ls values of 1.5, 2.0, 2.5, and 3.0 at each position of the marker
map (Kruglyak and Lander 1995; Kruglyak et al. 1996). All affected
sib pairs were used. There is no evidence to suggest linkage (LOD
score 1 0) for a locus of ls = 1.5, and a locus of ls = 2.5 can be formally
excluded (LOD score ! 2.0) from this region.
North American, Italian, Israeli, and British populations
(Tomer et al. 1998).
We have examined this chromosomal region in a ho-
mogeneous cohort of 71 affected GD sib pairs derived
from 64 multiplex British GD kindreds (146 subjects
with GD, 20 with autoimmune hypothyroidism [MIM
140300], and 72 unaffected). In six families, an addi-
tional sibling had autoimmune hypothyroidism, result-
ing in a total of 77 affected sib pairs with AITD (i.e.,
either GD or autoimmune hypothyroidism) (table 1).
Parents ( ) and unaffected sibs ( ) were stud-n = 49 n = 36
ied wherever available. All subjects were white, and
195% of the grandparents were from the mainland
United Kingdom or were of Irish origin. The clinical
definitions of GD and autoimmune hypothyroidismwere
identical to those described elsewhere (Tomer et al.
1998). Fifty-four (37%) of the patients with GD had
significant thyroid-associated orbitopathy (class 3 or
worse) (Werner 1977). Background allele frequencies
were derived from typing of DNA obtained from local
subjects without evidence of autoimmune disease. Non-
parametric, parametric, and exclusion-mapping analyses
were performed with the use of the GENEHUNTER
package, version 2.0 (Kruglyak et al. 1996). For para-
metric analyses, a population frequency of 1% for GD
was assumed, with a nonsusceptibility-genotype pene-
trance of .005, and allele frequencies were varied, ac-
cording to Hardy-Weinberg equilibrium, for each sus-
ceptibility-genotype penetrance studied.
Multipoint nonparametric analysis with the use of five
microsatellite markers spanning a 21-cM area of
20q13.11 showed no evidence to support linkage in the
71 GD sib pairs, with a peak NPL (nonparametric link-
age) score of 0.1 occurring at the marker D20S884 (fig.
1).Wewere able to formally exclude (LOD score !2.0)
a hypothetical GD locus with a from this entirel 1 2.5s
region (fig. 1). Parametric analysis was performed both
with and without the assumption of heterogeneity, with
both recessive and dominant models. There was no ev-
idence for linkage of GD to this region at disease pen-
etrances of 30%, 60%, or 90%, with either model of
inheritance, in the 71 sib pairs (table 2).
The ascertainment strategy (at least two affected sibs
with GD) used to recruit families for our study was
different from that (at least two affected first-degree rel-
atives with AITD) used by Tomer et al., such that their
cohort of families was likely to contain many more af-
fected parent-offspring kindreds (Tomer et al. 1998). We
speculated that such affected parent-offspring kindreds
might have enriched their cohort for families segregating
dominant loci and that this difference in ascertainment
might explain the apparent discrepancy between our
findings, if the susceptibility locus segregated as a dom-
inant (McCarthy et al. 1998). Therefore, we investigated
linkage both in a subgroup of 12 families (38 subjects
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Figure 2 Linkage analysis of the subset of 12 GD kindreds with
dominant transmission of GD, and other groups. A, Percentage in-
formation content for the 12 families with dominant transmission of
GD is shown at each of the map positions. B, Multipoint nonpara-
metric linkage analysis of the subsets of GD kindreds for chromosome
20q13.11 markers. Genotyping and linkage analysis were performed
as described in figure 1. There is an ∼4-cM region of excess allele
sharing between markers D20S106 and D20S884, encompassing
D20S195, in the families with dominant transmission ofGD (unbroken
line). The maximum evidence for linkage, an NPL score of 2.02
( ), occurs at marker D20S106. In contrast, there is no evidenceP = .023
to support linkage either in subsets of families with dominant trans-
mission of AITD (i.e., including kindreds with transmission from a
parent with autoimmune hypothyroid to offspring with GD, or vice
versa) or in families with only one generation affected by GD (dashed
lines).
Table 2
Peak Multipoint Parametric LOD Scores for the Chromosome 20q13.11 Markers in the 64
Families with GD and in the Subset of 12 Kindreds with Dominant Transmission of GD
LOD SCORE
Without Heterogeneity With Heterogeneity
PENETRANCE Dominant Recessive Dominant (a) Recessive (a)
All 64 kindreds:
30% 6.44 9.28 .01 (.05) .00 (.00)
60% 8.08 13.60 .01 (.05) .00 (.00)
90% 9.03 16.49 .01 (.05) .00 (.00)
12 Dominant kindreds:
30% .72 .12 1.05 (.73) .37 (.58)
60% .40 .20 1.06 (.68) .34 (.50)
90% .22 .43 1.06 (.66) .33 (.49)
with GD) who had apparent dominant transmission of
GD from parent to offspring and in a subgroup of 28
families with dominant transmission of AITD from par-
ent to offspring (75 subjects with GD and 17 with au-
toimmune hypothyroid). Multipoint nonparametric
analysis in the 12 families with dominant transmission
of GD showed a 4-cM plateau suggestive of linkage,
with a peak NPL score of 2.02 ( ) occurring atP = .023
the marker D20S106 (fig. 2). This was not observed in
the larger subgroup of 28 families with parent-to-off-
spring transmission of AITD (fig. 2). Parametric analysis
in the subgroup with dominant transmission of GD,with
the assumption of heterogeneity, showed a peak LOD
score of 1.06 occurring at the marker D20S884 with a
dominant model (table 2).
Our study provides some evidence to support the pres-
ence of a GD-susceptibility locus in this region of
20q13.11 (Tomer et al. 1998), and we show that this
locus appears to be important only in families with dom-
inant inheritance of GD. The small number of such kin-
dreds that we have studied precludes a reliable estimate
of the strength of effect of this locus, but our ability to
detect the effect using only 12 families with this struc-
ture, coupled with the 1:0 allele-sharing ratio of 69%
between the sib pairs with GD, suggests that it may have
a strong effect. In contrast, our families with affected
subjects with GD in only one generation and our families
with dominant transmission of AITD do not show ev-
idence of linkage to this locus (figs. 1 and 2). Analysis
of a larger cohort of kindreds with dominant transmis-
sion of GD is necessary to confirm the presence of this
susceptibility locus for GD. However, the recent map-
ping of a susceptibility locus for systemic lupus erythe-
matosus (MIM 152700) to this region of chromosome
20 in two different mixed American cohorts (Gaffney et
al. 1998; Moser et al. 1998) suggests that this region
may harbor a polymorphism(s) that is important in other
autoimmune disorders. In addition, our study illustrates
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that the ascertainment strategies employed in the col-
lection of cohorts of kindreds with complex disorders
may have a marked effect on the ability to detect a given
susceptibility locus (McCarthy et al. 1998).
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Primary Autosomal Recessive Microcephaly:
Homozygosity Mapping of MCPH4 to
Chromosome 15
To the Editor:
Microcephaly is a condition in which the head circum-
ference is smaller than !3 SD below the mean for age.
Syndromic microcephaly is found in a number of envi-
ronmental, chromosomal, or single-gene disorders.Non-
